American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists
-
Am J Health Syst Pharm · Feb 2010
Automated endotoxin testing program for high-risk-level compounded sterile preparations at an institutional compounding pharmacy.
An endotoxin testing program for high-risk-level compounded sterile preparations (CSPs) was verified for compliance with finished-preparation release test requirements of United States Pharmacopeia chapter 797 and implemented at an institutional compounding pharmacy. ⋯ A photometric endotoxins test that met all requirements of the BET was verified and implemented for high-risk-level CSPs prepared in an institutional pharmacy.
-
Am J Health Syst Pharm · Feb 2010
Stability of extemporaneously prepared rifaximin oral suspensions.
The stability of extemporaneously prepared rifaximin oral suspensions was studied. ⋯ Extemporaneously prepared suspensions of rifaximin 20 mg/mL in 1:1 mixtures of Ora-Plus with either Ora-Sweet or Ora-Sweet SF were stable for at least 60 days when stored in 2-oz amber plastic bottles at room temperature.
-
Am J Health Syst Pharm · Feb 2010
Symposium on roles of and cooperation between academic- and practice-based pharmacy clinicians.
The findings of an academic symposium as they relate to the history and role of the academic pharmacy clinician, the strengths and limitations of the academic pharmacy clinician model, and the framework for future synergistic work relations among clinical pharmacy practitioners are summarized. ⋯ A symposium attended by clinical faculty members and administrators from two colleges of pharmacy, practice-based clinical pharmacists and pharmacy managers from seven health care institutions, and representatives from three national pharmacy organizations was conducted to discuss the roles of and cooperation between academic- and practice-based pharmacy clinicians.
-
Am J Health Syst Pharm · Feb 2010
Case ReportsAcute pancreatitis associated with lisinopril and olanzapine.
A case of acute pancreatitis associated with lisinopril and olanzapine is described. ⋯ The additive effect of two known pancreatitis-causing medications resulted in increased risk and subsequent acute pancreatitis in this patient.